ACST

Acasti Pharma Inc. operates as a biopharmaceutical firm, concentrating its efforts on developing and marketing pharmaceutical solutions specifically for cardiovascular conditions. The company is currently exploring potential strategic alliances to further the clinical development of its drug candidate, CaPre. This Canadian company, which was established in 2002, has its main offices located in Laval.